Literature DB >> 26811413

Parvovirus leading to thrombotic microangiopathy in a healthy adult.

Bhanu Prasad1, Jennifer St Onge2.   

Abstract

A healthy 47-year-old man initially presented with symptoms of body rash, myalgias, dark urine, nausea and vomiting. Acute kidney injury, and positive urine analysis for blood and protein warranted a kidney biopsy, which revealed micro thrombi in kidney vasculature, suggestive of thrombotic microangiopathy. Serology revealed positive parvovirus B19 IgM antibodies and biopsy tests revealed a viral genome on PCR. Despite plasma exchanges and treatment with rituximab, renal function continued to deteriorate to end-stage renal disease. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26811413      PMCID： PMC4735274          DOI： 10.1136/bcr-2015-213492

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  8 in total

1.  Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation.

Authors:  Luisa Murer; Graziella Zacchello; Daniela Bianchi; Roberto Dall'amico; Giovanni Montini; Barbara Andreetta; Marino Perini; Elisabetta Currò Dossi; Gianfranco Zanon; Franco Zacchello
Journal:  J Am Soc Nephrol       Date:  2000-06       Impact factor: 10.121

2.  The prevalence of antibody to human parvovirus B19 in England and Wales.

Authors:  B J Cohen; M M Buckley
Journal:  J Med Microbiol       Date:  1988-02       Impact factor: 2.472

3.  Parvovirus B19 finds a disease.

Authors:  Y Cossart
Journal:  Lancet       Date:  1981-10-31       Impact factor: 79.321

4.  Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants.

Authors:  Sundararaman Swaminathan; Donna J Lager; Xiang Qian; Mark D Stegall; Timothy S Larson; Matthew D Griffin
Journal:  Nephrol Dial Transplant       Date:  2006-05-16       Impact factor: 5.992

Review 5.  Association of parvovirus B19 infection with acute glomerulonephritis in healthy adults: case report and review of the literature.

Authors:  Y Mori; H Yamashita; Y Umeda; Y Uchiyama-Tanaka; A Nose; N Kishimoto; Y Kijima; T Nagata; M Mori; H Matsubara; H Yoshida; T Iwasaka
Journal:  Clin Nephrol       Date:  2002-01       Impact factor: 0.975

6.  Parvovirus-like particles in human sera.

Authors:  Y E Cossart; A M Field; B Cant; D Widdows
Journal:  Lancet       Date:  1975-01-11       Impact factor: 79.321

Review 7.  Parvovirus B19 and the kidney.

Authors:  Meryl Waldman; Jeffrey B Kopp
Journal:  Clin J Am Soc Nephrol       Date:  2007-07       Impact factor: 8.237

8.  Parvovirus B19-induced multisystem disease simulating systemic vasculitis in a young child.

Authors:  Rashna Dass; P Ramesh; R K Ratho; Akshay Kumar Saxena; Surjit Singh
Journal:  Rheumatol Int       Date:  2004-04-16       Impact factor: 3.580
  8 in total
  4 in total

1.  Parvovirus B19 infection and kidney injury: report of 4 cases and analysis of immunization and viremia in an adult cohort of 100 patients undergoing a kidney biopsy.

Authors:  Maëlis Kauffmann; Mickaël Bobot; Laurent Daniel; Julia Torrents; Yannick Knefati; Olivier Moranne; Stéphane Burtey; Christine Zandotti; Noémie Jourde-Chiche
Journal:  BMC Nephrol       Date:  2020-07-09       Impact factor: 2.388

2.  Extensive purpura as presenting sign of parvovirus B19 infection in a patient with paroxysmal nocturnal hemoglobinuria.

Authors:  Mimi Nguyen; Samantha Ellis; Thomas H Konia; Alain Brassard; Danielle Tartar
Journal:  JAAD Case Rep       Date:  2019-08-29

3.  Hemophagocytic lymphohistiocytosis and thrombotic microangiopathy after parvovirus B19 infection and renal transplantation: a case report.

Authors:  C J Steffen; N Koch; K U Eckardt; K Amann; E Seelow; A Schreiber
Journal:  BMC Nephrol       Date:  2021-10-12       Impact factor: 2.388

4.  Ockham's razor defeated: about two atypical cases of hemolytic uremic syndrome.

Authors:  Chloe Schwarz; Alice Brehon; Cyril Mousseaux; Yosu Luque; Patricia Senet; Patricia Mariani; Inna Mohamadou; Lara Zafrani; Véronique Frémeaux-Bacchi; Eric Rondeau; David Buob; Cédric Rafat
Journal:  BMC Nephrol       Date:  2020-07-11       Impact factor: 2.388
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.